Unlock instant, AI-driven research and patent intelligence for your innovation.

The miRNA molecules that negatively regulate the type I interferon pathway and their applications

A technology of interferon and type I, applied in the field of molecular biology, can solve the problem of little research work on miRNA function

Active Publication Date: 2016-05-04
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, there is little research on the function of miRNAs in the type 1 interferon pathway

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The miRNA molecules that negatively regulate the type I interferon pathway and their applications
  • The miRNA molecules that negatively regulate the type I interferon pathway and their applications
  • The miRNA molecules that negatively regulate the type I interferon pathway and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] Example 1, Hsa-miR-127-3p can significantly inhibit TypeIIFN-induced ISRE / GAS-luciferase (luciferase) activity

[0077] The inventor co-transfected ISRE or GAS reporter gene carrier and Hsa-miR-127-3pmimics or negative control (NC) mimics in Hela cells, and after TypeIIFN stimulation for 6hr, the luciferase activity was detected with a dual-luciferase reporter gene assay system , found that Hsa-miR-127-3p can inhibit TypeIIFN-induced ISRE-Luciferase (luciferase) activity ( figure 1 A) or GAS-Luciferase (luciferase) activity ( figure 1 B).

[0078] This result indicated that Hsa-miR-127-3p could inhibit the TypeIIFN pathway.

[0079] The function of microRNA mainly depends on the sequence of its seed region, so the inventors designed the mutants seedmut1 and seedmut2 of hsa-miR-127-3p seed region sequence. The sequence is as follows (the underline indicates the modified base):

[0080] hsa-miR-127-3pseedmut1 (SEQ ID NO: 10):

[0081] 5'UCGGAUCCGUCUGAGCUUGGCU3' (SEQ ...

Embodiment 2

[0088] Example 2, Hsa-miR-127-3p can significantly inhibit the expression of downstream genes induced by TypeIIFN

[0089] In order to further verify the function of Hsa-miR-127-3p in the TypeIIFN pathway, the inventors transferred Hsa-miR-127-3pmimics into Hela cells, and after TypeIIFN stimulation for 6 hours, the downstream gene expression induced by TypeIIFN was detected, compared with the control In contrast, Hsa-miR-127-3pmimics can significantly inhibit TypeIIFN-induced expression of downstream genes such as CCL2, CXCL10 and IFIT3 ( figure 2 A).

[0090] After stimulation, the protein expression levels of CCL2 and CXCL10 in the supernatant were detected. The results showed that Hsa-miR-127-3p could significantly inhibit the expression of CCL2 and CXCL10 ( figure 2 B). This shows that Hsa-miR-127-3p can indeed negatively regulate the expression of genes downstream of the TypeIIFN pathway.

Embodiment 3

[0091] Example 3, Hsa-miR-127-3p participates in the negative regulation of the TypeIIFN pathway by inhibiting the phosphorylation of STAT1 and STAT2

[0092] It has been reported that in the TypeIIFN pathway, after TypeIIFN binds to its receptor, it activates downstream phosphokinases, further phosphorylates STAT1 and STAT2, and activates them. Phosphorylated STAT1 and STAT2 enter the nucleus and activate TypeIIFN-induced genes. Expression [Platanias, L.C. Mechanisms of type-I-andtype-II-interferon-mediated signaling. Nature Reviews Immunology. 2005.5(5):375-386]. Phosphorylated STAT1 and STAT2 play an important role in the activation of the entire TypeIIFN pathway, so the inventors doubt whether Hsa-miR-127-3p can participate in regulating the TypeIIFN pathway by affecting the phosphorylation of STAT1 and STAT2. The inventors transferred Hsa-miR-127-3pmimics into Hela cells, and after TypeIIFN stimulation for 6 hours, the inventors found by Western Blot that compared with th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a miRNA molecule negatively regulating type I interferon pathway and application thereof. For the first time, it was discovered and proved that the small RNA Hsa-miR-127-3p is closely related to systemic lupus erythematosus. The present inventors further verified the target pathway of the miRNA, and found that Hsa-miR-127-3p can inhibit type I interferon pathway, so it can be used to prevent and treat diseases related to abnormal activation of type I interferon pathway.

Description

technical field [0001] The invention belongs to the field of molecular biology; more specifically, the invention relates to miRNA molecules negatively regulating type I interferon pathways and applications thereof. Background technique [0002] Type Ι interferon is a class of cytokines with anti-virus, anti-bacterial infection and immune regulation functions, and plays an important role in innate immunity and adaptive immunity [Theofilopoulos, A.N., R.Baccala, et al.TypeI Interferons (α / β) in Immunity and Autoimmunity. Annual Review of Immunology. 2005.23 (1): 307-335]. Recent studies have found that in the autoimmune disease systemic lupus erythematosus, the type Ⅲ interferon pathway is abnormally activated, and the activated type Ⅲ interferon pathway can activate self-reactive T cells, DC cells and B cells, etc., thereby promoting autoimmunity Reaction, aggravating systemic lupus erythematosus [Virginia Pascual, Jacques Banchereau. Systemic Lupus Erythematosus and Type I ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00C12Q1/68G01N33/68A61P37/02A61P3/10A61P21/00A61P17/00A61P19/02A61P29/00A61P25/28A61P25/00
CPCA61K31/713A61P3/10A61P17/00A61P19/02A61P21/00A61P25/00A61P25/28A61P29/00A61P37/02C12N2310/113C12N2310/141
Inventor 沈南曲波韩晓梁栋
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI